| Serous macular detachment in retinal vascular disease | Hakan ÖZDEMİR | 79–82 |
| Serous macular detachments in inflammatory diseases | Merih SOYLU | 83–85 |
| Other diseases and serous retinal detachment | Berkant KADERLİ | 86–89 |
| Our therapeutic approach in central serous chorioretinopathy | Melisa Zişan KARSLIOĞLU,Emin ÖZMERT,Figen BATIOĞLU | 90–96 |
| Yaşa bağlı maküla dejenerasyonuna bağlı koroidal neovaskülarizasyon tedavisinde tek başına bevacizumab veya fotodinamik tedavi ile kombinasyon: 12 ay sonuçları | BERRAK ŞEKERYAPAN GEDİZ,Şengül ÖZDEK,MEHMET CÜNEYT ÖZMEN,Gökhan GÜRELİK,Berati HASANREİSOĞLU | 97–102 |
| Factors affecting the final visual acuity and anatomical success in intravitreal ranibizumab applications in age-related macular degeneration | Nurten ÜNLÜ,Dicle HAZIROLAN,MEHMET AKİF ACAR,Damla ACAR ERGİNTÜRK,Güner ÜNEY ÖZKAN,Esra KARABULUT | 103–107 |
| Efficacy of intravitreal ranibizumab (Lucentis®) injection for the treatment of macular edema secondary to retinal vein occlusion | Volkan EKEN,Figen BATIOĞLU,Emin ÖZMERT | 108–112 |
| Long-term results of laser photocoagulation in proliferative diabetic retinopathy | Hüseyin ASLANKARA,Duygu TÜRÜTHAN,Sayime AYDIN,Hakan F. ÖNER,Mehmet H. ERGİN | 113–116 |
| Maküla ödemi tedavisinde kullanılan intravitreal enjeksiyonların göz içi basıncına etkisi | Ahmet Taylan YAZICI,Cengiz ALAGÖZ,Neşe ALAGÖZ,Hüseyin DÜNDAR,Ercüment BOZKURT,Mehmet ÇAKIR,Ömer Faruk YILMAZ | 117–121 |
| Results of pars plana capsulectomy and anterior vitrectomy in cases which Nd:YAG capsulotomy was inappropriate | EMRE AYINTAP,Mesut COŞKUN,Özgür İLHAN,Uğurcan KESKİN,Esra TUZCU AYHAN,Hüseyin ÖKSÜZ | 122–126 |
| Comparison of silicone oil removal using 23 gauge and 20 gauge sclerotomy systems | Selim DOĞANAY,Bekir KOÇ,CEM ÇANKAYA,Soner DEMİREL | 127–130 |
| Intravitreal ranibizumab for the treatment of choroidal neovascularization in Best’s vitelliform macular dystrophy |